Diclofenac Sodium Topical Gel — Class III drug recall D-0291-2026
Ongoing recall by Cipla USA, Inc., reported 2026-01-28, distributed nationwide. Failed PH Specifications
| Recall number | D-0291-2026 |
|---|---|
| Product type | Drug |
| Classification | Class III |
| Status | Ongoing |
| Voluntary or mandated | Voluntary |
| Recalling firm | Cipla USA, Inc., Warren, NJ, United States |
| Recall initiated | 2025-12-22 |
| Classified | 2026-01-20 |
| Reported by FDA | 2026-01-28 |
| Distributed | Nationwide (US) |
| Quantity | 92,376 tubes |
| NDC | 76282-0103, 76282-0103-39 |
| Expiration dates | 2027-08-31 |
Product
Diclofenac Sodium Topical Gel, 1%, NET WT 100 g (3.53 oz), Manufactured by: DPT Laboratories, Ltd., 307 E Josephine Street, San Antonio, TX 78215. NDC: 76282-103-39
Reason for recall
Failed PH Specifications
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0291-2026. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.